ArticleEquine veterinary journal2026
Clinical signs, clinical pathology and outcomes in horses infected naturally with equine encephalosis virus.
Article in Equine veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isolation and Identification of Emerging Equine Encephalosis Virus Serotype 6 in Israel, 2023.Pathogens (Basel, Switzerland) · 2026Article
- Clinical signs, clinical pathology and outcomes in horses infected naturally with equine encephalosis virus.Equine veterinary journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEquine encephalosis (EE) is caused by an Orbivirus from the family Sedoreoviridae and is thus similar to African horse sickness (AHS) and Bluetongue viruses (BTV). These viruses are transmitted by Culicoides midges. Equine encephalosis can infect horses, donkeys and zebras sub-clinically while only horses develop clinical disease. The vector's distribution is climate-dependent with evidence for circulation in Southern Africa, the Middle East and India. Global warming could facilitate the expansion of this distribution and consequently the potential spread into Europe should not be overlooked.
objectivesTo describe clinical signs, clinicopathological abnormalities, and outcomes in horses naturally infected with EE. STUDY
designA retrospective, descriptive, observational study.
methodsData were obtained from the Onderstepoort Veterinary Academic Hospital's clinical database to identify cases with EE from 2013 to 2023. Data including the history, clinical signs and clinicopathology were analysed.
resultsEquine encephalosis cases predominantly occurred from February to April. Twenty-five horses were included. Throughout the disease, 25 (100.0%) horses had pyrexia (mean maximum temperature 39.3°C; SD 0.86°C), 16 (64.0%) horses had tachycardia (median maximum heart rate 52/min; range 36-100/min), 19 (76.0%) horses had tachypnoea (median maximum respiratory rate 24/min; range 12-60/min). Within 24 h of presentation, horses predominantly displayed lymphopenia (median 1.17 × 10 MAIN LIMITATIONS: Retrospective study design with a small number of cases and many of these evaluated at differing times after infection.
conclusionPyrexia, tachycardia and tachypnoea are the most common clinical signs associated with EE. Haematological evaluation appears valuable in EE cases, with leukopenia, lymphopenia, and thrombocytopenia commonly observed. Equine encephalosis is a relevant differential diagnosis for other infectious diseases in horses in geographical regions where EEV and Culicoides vectors are potentially present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.